Your Cart Is Empty!
Market barriers affect nearly 40% of growth hormone prescriptions in the US, and most brands lose market share because of them.
But one brand has turned those barriers to its advantage, boosting its net share by more than 5% to claim the #2 spot.
Find out how barriers affect your brand in Market Access Impact: GHD.
The report covers 7 major growth hormone brands: Genotropin, Humatrope, Norditropin, NutropinAq, Omnitrope, Saizen, and Zomacton.
You’ll learn which barriers cost you the most share, which brands you’re losing it to, and which ones you’re taking it from—information you can use to improve your market access strategy.
Get Answers to Key Questions about Growth Hormone Brands
Genotropin (somatropin; Pfizer): Which two leading brands take the bulk of Genotropin’s lost market share?
Humatrope (somatropin; Eli Lilly): What’s the one surveyed brand that’s more easily reimbursed than Humatrope?
Norditropin (somatropin; Novo Nordisk): Which competitor could threaten Norditropin if it can manage to overcome market barriers?
NutropinAq (somatropin; Genentech): Is cost or limited availability costing NutropinAq more market share?
Omnitrope (somatropin; Sandoz): Omnitrope and NutropinAq are running neck and neck for market share. Which one would pull ahead if market barriers didn’t exist?
Saizen (somatropin; EMD Serono): Which two market barriers do fewer doctors experience with Saizen than any other brand?
Zomacton (somatropin; Ferring): Zomacton loses share to both Genotropin and Humatrope. Which one does it also take share from?
Market access is the issue in the US. Barriers related to market access affect more than twice as many prescriptions as all other barriers combined.
One brand wins big. Of the two brands that gain share due to market barriers, one gains more than three times as much as the other.
Eliminating barriers would shake up the market, knocking the 2nd place brand down to 3rd place and widening the gap between the current 4th and 5th place brands.
Two brands facing awareness issues. Nearly 20% of doctors surveyed are not aware of the two least-prescribed brands. Awareness for the other five brands is high.
“Other” brands benefit too. Six of the surveyed brands see a net share loss to other brands (not surveyed). In aggregate, these brands see the second largest barrier-related share gain.
US somewhat more active than Europe. US endocrinologists prescribe all but one of the surveyed brands more often than their European counterparts do.
Top 3 brands are the same in US and Europe. Endocrinologists in both markets most often prescribe the same three leading brands.
Market Access Impact: GHD explores key issues affecting Growth Hormone manufacturers. You’ll learn:
How barriers affect market access:
What brands do doctors prescribe the most?
How many prescriptions do barriers affect?
Which barriers have the biggest impact?
How barriers affect your brand:
How many doctors prescribe your brand? How many don’t, but would consider it?
Why don’t doctors prescribe your brand? What do they prescribe instead?
Which competing brands does your brand take market share from?
A Report Based on Expert Knowledge
We surveyed 100 adult and paediatric endocrinologists in the US, chosen from the largest community of validated physicians in the world.
All respondents have:
Been practicing for 2+ years
Prescribed at least one of the listed products
Seen at least 5 patients with melanoma in total in the last month
We conducted the survey between May 6th and 10th, 2016.
MONEY BACK GUARANTEE!
At FirstWord, we stand behind our reports. If you're not completely satisfied, we’ll refund your money. Guaranteed.
Table of Contents
Following are different modes of Licenses.
a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.
b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.
c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.
1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :
a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]
b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]
2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:
a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.